Tuchman tucks in as CMO of Oncolytics
This article was originally published in Scrip
Executive Summary
Oncolytics Biotech has appointed Dr Alan Tuchman chief medical officer and senior vice-president of clinical and medical development. Dr Tuchman is currently managing director at MedPro Investors and chair of Neurophysics (where he was previously CEO). He has served on Oncolytics’ scientific advisory board since 2001.